Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.35 is in line with its 5-year average of -0.38, around the middle of its 5-year range (-0.54–-0.25).
40.00% below its 12-month average of -0.25.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.14.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 31 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T16:02:30.854Z. Historical observations retain their original dates. Historical series through 2023-03-31.
EARNINGS PER SHARE (EPS)
-0.35
EARNINGS PER SHARE (EPS) AVG TTM
-0.25
EARNINGS PER SHARE (EPS) AVG 3Y
-0.32
EARNINGS PER SHARE (EPS) AVG 5Y
-0.38
EARNINGS PER SHARE (EPS) AVG 10Y
-0.54
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-40.00%
CURRENT VS 3Y AVG
-11.11%
CURRENT VS 5Y AVG
+7.49%
CURRENT VS 10Y AVG
+34.63%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Entera Bio Ltd.
Market Cap
$128.40M
Earnings Per Share (EPS)
-0.35
TTM Avg
-0.25
3Y Avg
-0.32
5Y Avg
-0.38
Market Cap
$124.91M
Earnings Per Share (EPS)
-0.74
TTM Avg
-1.87
3Y Avg
-2.08
5Y Avg
-2.08
Market Cap
$131.53M
Earnings Per Share (EPS)
-3.68
TTM Avg
-1.85
3Y Avg
-2.09
5Y Avg
-2.42
Market Cap
$123.03M
Earnings Per Share (EPS)
-0.28
TTM Avg
-1.88
3Y Avg
-2.46
5Y Avg
-1.80
Market Cap
$122.89M
Earnings Per Share (EPS)
-1.65
TTM Avg
-6.80
3Y Avg
-14.48
5Y Avg
-27.17
Market Cap
$133.13M
Earnings Per Share (EPS)
0.45
TTM Avg
-0.23
3Y Avg
-0.84
5Y Avg
-0.86
Market Cap
$121.32M
Earnings Per Share (EPS)
-0.54
TTM Avg
-0.92
3Y Avg
-84.40
5Y Avg
-674.41
Market Cap
$134.69M
Earnings Per Share (EPS)
-0.51
TTM Avg
-0.38
3Y Avg
-0.76
5Y Avg
-1.59
Market Cap
$134.80M
Earnings Per Share (EPS)
-1.41
TTM Avg
-1.30
3Y Avg
-2.00
5Y Avg
-1.82
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Entera Bio Ltd. (ENTX) | $128.40M | -0.35 | -0.25 | -0.32 | -0.38 |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $124.91M | -0.74 | -1.87 | -2.08 | -2.08 |
| Health Catalyst, Inc. (HCAT)vs › | $131.53M | -3.68 | -1.85 | -2.09 | -2.42 |
| enGene Holdings Inc. (ENGN)vs › | $123.03M | -0.28 | -1.88 | -2.46 | -1.80 |
| Cibus, Inc. (CBUS)vs › | $122.89M | -1.65 | -6.80 | -14.48 | -27.17 |
| Organigram Global Inc. (OGI)vs › | $133.13M | 0.45 | -0.23 | -0.84 | -0.86 |
| TuHURA Biosciences, Inc. (HURA)vs › | $121.32M | -0.54 | -0.92 | -84.40 | -674.41 |
| LifeMD, Inc. (LFMD)vs › | $134.69M | -0.51 | -0.38 | -0.76 | -1.59 |
| Pyxis Oncology, Inc. (PYXS)vs › | $134.80M | -1.41 | -1.30 | -2.00 | -1.82 |
| LENZ Therapeutics, Inc. (LENZ)vs › | $118.88M | -4.09 | -2.59 | -6.03 | -6.97 |
Trailing EPS (TTM)
$-0.35
Forward EPS (Est.)
$-0.42
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.25 |
| 2024-12-31 | -0.25 |
| 2023-12-31 | -0.31 |
| 2022-12-31 | -0.45 |
| 2021-12-31 | -0.47 |
| 2020-12-31 | -0.54 |
| 2019-12-31 | -0.90 |
| 2018-12-31 | -0.91 |
| 2017-12-31 | -1.31 |
| 2016-12-31 | -0.14 |
| 2015-12-31 | -0.36 |
